Newbornscreening kuwait
-
Upload
newborn-screening-kw -
Category
Health & Medicine
-
view
227 -
download
1
Transcript of Newbornscreening kuwait
![Page 1: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/1.jpg)
Expanded Newborn
Screening:
Clinical Impact
(Tandem ms/ms)
DR.AMIR ABDELAZIM
CLINICAL PATHOLOGY SPECIALIST
![Page 2: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/2.jpg)
Newborn Screening
A state mandated public
health program that begins
with a “heel poke” for every
baby before hospital discharge
First screen must be taken 48-52
hours of life regardless of
feeding status or weight
Blood Sample on Guthrie Filter Paper Card
![Page 3: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/3.jpg)
Who is screened?
Every newborn must be tested prior to discharge
from the hospital or within five days of age
Second screen strongly recommended between
7 and 14 days of age for sick and premature
baby
Third screen recommended for sick and
premature infants
![Page 4: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/4.jpg)
Why do newborn screening?
Screen a presumably healthy
newborn population
Detect disease before
symptoms present clinically
Goal: Prevent or reduce
morbidity and mortality
![Page 5: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/5.jpg)
Criteria for Newborn
Screening
Important condition
Acceptable treatment available
Facilities for diagnosis and treatment
Difficult to recognize early
Suitable screening test
Natural history known
Cost-effective to diagnose and treat
Wilson & Jungner, 1968
![Page 6: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/6.jpg)
Tandem Mass Spectrometry
(MS/MS) High Impact and High
Throughput
Many diseases, one test is cost-effective
MS/MS allows for rapid, simultaneous analysis
and detection of many disorders of amino
acid, organic acid, and fatty acid metabolism
![Page 7: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/7.jpg)
Tandem Mass
Spectrometer (MS/MS)
![Page 8: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/8.jpg)
MS/MS Methodology
Blood spots punched (3/16th inch disc)
Stable isotope internal standards added
Butyl esters derivatives made (in derivatisedmethod)
Automatic injection into MS/MS via 96 well plates
Sample set up determines which masses and therefore which compounds are detected
2 minute analysis time
Automated data processing for results
![Page 9: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/9.jpg)
MS/MS Methodology –
continued
Compounds analyzed are amino acids and acylcarnitines
Amino acids – to identify PKU, MSUD, homocystinuria , cittrulinemia ,ASA , Tyrosinemia
Acylcarnitine –for identification of organic acidurias and fatty acid oxidation disorders
![Page 10: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/10.jpg)
*
* ** *
*
C2
100%
Inte
ns
ity
* internal standards
Control
Inte
ns
ity
100%
*
* * *
*
*
MCAD
C2
C16
C8
C10:1C6
MS/MS Plasma Acylcarnitines
![Page 11: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/11.jpg)
MS/MS Plasma Amino Acids
![Page 12: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/12.jpg)
What is the scope of newborn
screening?
Screen ~60,000 newborns
Track ~ infants with abnormal results
Prevent ~ babies from death or disability
![Page 13: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/13.jpg)
Which disorders should be
identified?
Kuwait National NBS screen for 22 disorders
Screen tests done for all newborn inside Kuwait
New disorders plan to test in the future
![Page 14: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/14.jpg)
Amino Acid Disorders
AA that are not used to make proteins are recycled by their specific metabolic pathways.
Enzymatic deficiencies in these pathways lead to various clinical phenotypes.
Diagnosed by plasma amino acids, urine amino acids, and/or urine organic acids (takes 2-5 days)
PKU: severe, permanent ID
MSUD: ID, hallucinations, ataxia
HCY: connective tissue damage (joints, heart), ID, psychiatric disturbances
CIT: risk of hyperammonemia ID, coma, death
ASA: brittle hair, liver disease ID
TYR I: acute or chronic liver disease, liver cancer, neurologic pain crises
![Page 15: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/15.jpg)
Organic Acid Disorders
Organic acids are breakdown products of protein and fatty acid metabolism. Defects in their breakdown lead to (generally): Vomiting, metabolic
acidosis, elevated ammonia in crises
ID, motor delay, ataxia, cardiac/renal/pancreatic problems
Diagnosed by urine organic acids and/or plasma acylcarnitines
IVA: Isovaleric acidemia
GA I: Glutaric acidemia type I
HMG: 3-OH 3-CH3 glutaric aciduria
MCD: Multiple carboxylase deficiency
MUT: Methylmalonic acidemia (mutase deficiency)
3MCC: 3-Methylcrotonyl-CoA carboxylase deficiency
Cbl A,B: Methylmalonic acidemia
PROP: Propionic acidemia
BKT: Beta-ketothiolase deficiency
![Page 16: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/16.jpg)
Fatty Acid Disorders
Fatty acid disorders lead to impaired energy production
Hypoglycemia, cardiomyopathy, muscle weakness can be seen
Diagnosed by plasma acylcarnitines, and urine organic acids can be helpful
MCAD: Medium-chain acyl-CoA dehydrogenase deficiency
VLCAD: Very long-chain acyl-CoA dehydrogenase deficiency
LCHAD: Long-chain L-3-OH acyl-CoA dehydrogenase deficiency
TFP: Trifunctional protein deficiency
![Page 17: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/17.jpg)
Who is identified?
1. Patients who need active management
Symptomatic at diagnosis
Strong evidence of pathology if untreated
Examples: PKU, classic galactosemia, MSUD,
PROP, etc.
![Page 18: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/18.jpg)
Who is identified?
2. Patients with disorders known to pose risk but
reduced penetrance
i.e., probably not everyone needs to be treated
HPHE, MCAD
Both are/have mild ends of the spectrum that
have only been identified through NBS
MCAD mutation c.199 C>T
Never seen in patients picked up clinically
![Page 19: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/19.jpg)
Who is identified?
3. Patients who may not need any management
Disorders considered extremely rare but seen in
large numbers via NBS programs
Reported cases have significant morbidity
NBS pickups are mostly mild
3MCC, SCAD
Biochemical phenotype
![Page 20: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/20.jpg)
What are we screening
for?
8 OA 4 FAO 6 AA4 Others
IVA
GA I
HMG
MCD
MUT
3MCC
Cbl A,B
PROP
BKT
MCAD
VLCAD
LCHAD
TFP
PKU
MSUD
HCY
CIT
ASA
TYR I
CH
BIOT
CAH
GALT
![Page 21: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/21.jpg)
Components of Newborn
Screening
Sampling
hospital NSO
Screening
Tandem & DELFIA Labs
Reporting
to NSOs
Referral
to endocrine&metabolic sp.
for follow up and monitoring
![Page 22: Newbornscreening kuwait](https://reader031.fdocuments.us/reader031/viewer/2022021507/58f260701a28ab0c3c8b45a7/html5/thumbnails/22.jpg)
Effective NBS requires a
close working relationship
between hospitals NSOs,
newborn screening labs,
co-ordinators ,endocrine
specialist and metabolic
specialist .